Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
67%
Ph phase_2
3
33%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
3(33.3%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(4)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (33.3%)
N/A6 (66.7%)

Trials by Status

completed444%
recruiting111%
unknown333%
not_yet_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9